Nursa vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 52)
Nursa logo

Nursa

ChallengerHealthcare

Nurse & Clinician Staffing Platform

Nursa connects 400,000+ verified clinicians (RNs, LPNs, CNAs) with facilities for flexible PRN shifts; raised $103M (Series B led by Drive Capital); launched AI scheduling in September 2025; serves facilities nationwide.

AI VisibilityBeta
Overall Score
C52
Category Rank
#297 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
50
Perplexity
49
Gemini
52

About

Nursa is a Salt Lake City-based healthcare staffing platform that connects nurses and other healthcare professionals with hospitals, nursing homes, and care facilities that need short-term clinical staff. The platform offers verified clinicians — including Registered Nurses (RNs), Licensed Practical Nurses (LPNs), and Certified Nursing Assistants (CNAs) — the ability to browse and book PRN (as-needed) shifts on flexible schedules, giving them income control without the constraints of traditional agency placement. For facilities, Nursa provides on-demand access to a pool of over 400,000 verified, local clinicians to fill staffing gaps quickly and cost-effectively.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

52
Overall Score
90
#297
Category Rank
#2
81
AI Consensus
83
stable
Trend
stable
50
ChatGPT
92
49
Perplexity
93
52
Gemini
89
52
Claude
96
57
Grok
95

Key Details

Category
Nurse & Clinician Staffing Platform
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.